Community Pharmacy England (CPE) - News updates
Sector Poll: Tell us about patient abuse and other challenges
Community pharmacy owners are being asked to share their experiences of patient abuse towards them and their teams, and other challenges, as the Community Pharmacy England Committee prepares for its first meeting of 2026. Pharmacy owners and their teams continue to work hard to support local communities despite mounting pressures, and this is made even [...] The post Sector Poll: Tell us about patient abuse and other challenges appeared first on Community Pharmacy England.
CPE and Luther Pendragon Named Finalists at Public Affairs Awards 2026
Community Pharmacy England’s political influencing work with our public affairs partner, Luther Pendragon, has been recognised in the Public Affairs Awards 2026. Together, Luther Pendragon and Community Pharmacy England have been selected as finalists in the category of Best In-House Consultancy Collaboration for our joint campaign to press for increased funding for community pharmacies. The recognition reflects the impact of our work together to help secure further investment for [...] The post CPE and Luther Pendragon Named Finalists at Public Affairs Awards 2026 appeared first on Community Pharmacy England.
Pharmacies manage surging flu vaccine demand
The Independent, The Guardian, Daily Mail, The Sun, Yahoo News, LBC News Reports in the media have suggested that pharmacies across England are running low on flu vaccines, with potential shortages of appointments in some isolated areas. Reports indicate that a particularly infectious strain is driving what could be the worst flu season on record [...] The post Pharmacies manage surging flu vaccine demand appeared first on Community Pharmacy England.
Flu Vac: Vaccine stock availability
Following public calls to encourage people to get their flu vaccination to be protected ahead of the festive holidays, NHS England has assured pharmacy owners that flu vaccine stocks remain available to order. Where pharmacy owners have exhausted their original flu vaccine stock, flu vaccine supply may still be available from some wholesalers. Alternatively, as [...] The post Flu Vac: Vaccine stock availability appeared first on Community Pharmacy England.
MHRA Class 2 Medicines Recall: Clarithromycin 500 mg powder for concentrate for solution for infusion (Hameln Pharma Ltd)
MHRA Class 2 Medicines Recall: Clarithromycin 500 mg powder for concentrate for solution for infusion (Hameln Pharma Ltd) Drug alert number: EL(25)A/53 Date issued: 11 December 2025 Hameln Pharma Ltd is recalling certain batches of Clarithromycin 500 mg powder for concentrate for solution for infusion. DMRC reference number: DMRC-37790612 Company name: Hameln Pharma ltd Medicine Details [...] The post MHRA Class 2 Medicines Recall: Clarithromycin 500 mg powder for concentrate for solution for infusion (Hameln Pharma Ltd) appeared first on Community Pharmacy England.
Curbing patient abuse
Pharmacy owners and their teams work hard to support local communities every day, but more than half of pharmacy staff reported that abuse from patients is a serious concern in the 2025 Pharmacy Pressures Survey. If you face any type of abuse from patients, please don’t feel like you have to tolerate it. The following [...] The post Curbing patient abuse appeared first on Community Pharmacy England.
Improved price concession for Propranolol 40mg tablets for November 2025
Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the November 2025 concessionary price for Propranolol 40mg tablets: Drug Pack size Price concession Propranolol 40mg tablets 28 £2.28 (previously £1.61) The improved price will apply to prescriptions submitted for payment for [...] The post Improved price concession for Propranolol 40mg tablets for November 2025 appeared first on Community Pharmacy England.
Class 4 Medicines Defect Notification: Amitriptyline hydrochloride 10mg, 25mg, 50mg tablets (Flamingo Pharma UK Ltd)
MHRA Class 4 Medicines Defect Notification: Amitriptyline hydrochloride 10mg, 25mg, 50mg tablets (Flamingo Pharma UK Ltd) Drug alert number: EL(25)A/52 Date issued: 10 December 2025 Flamingo Pharma UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information. DMRC reference [...] The post Class 4 Medicines Defect Notification: Amitriptyline hydrochloride 10mg, 25mg, 50mg tablets (Flamingo Pharma UK Ltd) appeared first on Community Pharmacy England.
Joint Primary Care Statement on the Budget 2025
Following on from the Budget announcement at the end of November, Community Pharmacy England has joined forces with other national primary care bodies to reiterate our call on Government to commit to “clear and decisive action” to support primary care. The joint statement, copied below, has been signed by Community Pharmacy England, the British Dental [...] The post Joint Primary Care Statement on the Budget 2025 appeared first on Community Pharmacy England.
Medicine Supply Notification: Nifedipine (Fortipine® LA) 40mg modified-release tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Nifedipine (Fortipine® LA) 40mg modified-release tablets. MSN/2025/064 Tier 2 – medium impact Date of issue: 8th December 2025 Nifedipine (Fortipine® LA) 40mg modified-release tablets are currently out of stock. The resupply date is yet to be confirmed. Other brands of nifedipine [...] The post Medicine Supply Notification: Nifedipine (Fortipine® LA) 40mg modified-release tablets appeared first on Community Pharmacy England.